Industry
Scotmann Pharmaceuticals
Total Trials
6
Recruiting
0
Active
1
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
N/A
2(33.3%)
Phase 2
2(33.3%)
Phase 3
2(33.3%)
6Total
N/A(2)
Phase 2(2)
Phase 3(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT06437080Not ApplicableActive Not Recruiting
Hypoferritinemia Without Anemia Among Reproductive Age Females
Role: collaborator
NCT05080530Not ApplicableUnknown
Vitamin D and Painful Diabetic Neuropathy
Role: collaborator
NCT05417880Phase 3Unknown
Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus
Role: lead
NCT05104970Phase 2Unknown
Comparative Pharmacokinetics of Two Different Oral Delivery Systems of Cholecalciferol
Role: lead
NCT05088928Phase 2Unknown
Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care
Role: lead
NCT05104918Phase 3Unknown
Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities
Role: lead
All 6 trials loaded